Literature DB >> 32758615

Application of advances in endocytosis and membrane trafficking to drug delivery.

Yaping Ju1, Hao Guo1, Maria Edman2, Sarah F Hamm-Alvarez3.   

Abstract

Multidisciplinary research efforts in the field of drug delivery have led to the development of a variety of drug delivery systems (DDS) designed for site-specific delivery of diagnostic and therapeutic agents. Since efficient uptake of drug carriers into target cells is central to effective drug delivery, a comprehensive understanding of the biological pathways for cellular internalization of DDS can facilitate the development of DDS capable of precise tissue targeting and enhanced therapeutic outcomes. Diverse methods have been applied to study the internalization mechanisms responsible for endocytotic uptake of extracellular materials, which are also the principal pathways exploited by many DDS. Chemical inhibitors remain the most commonly used method to explore endocytotic internalization mechanisms, although genetic methods are increasingly accessible and may constitute more specific approaches. This review highlights the molecular basis of internalization pathways most relevant to internalization of DDS, and the principal methods used to study each route. This review also showcases examples of DDS that are internalized by each route, and reviews the general effects of biophysical properties of DDS on the internalization efficiency. Finally, options for intracellular trafficking and targeting of internalized DDS are briefly reviewed, representing an additional opportunity for multi-level targeting to achieve further specificity and therapeutic efficacy.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CAM-endocytosis; Caveolae-mediated endocytosis; Clathrin-mediated endocytosis; Drug carrier; Drug delivery; Endocytosis; Imaging; Macropinocytosis; Phagocytosis

Year:  2020        PMID: 32758615      PMCID: PMC7853512          DOI: 10.1016/j.addr.2020.07.026

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  371 in total

1.  Ikarugamycin: A Natural Product Inhibitor of Clathrin-Mediated Endocytosis.

Authors:  Sarah R Elkin; Nathaniel W Oswald; Dana K Reed; Marcel Mettlen; John B MacMillan; Sandra L Schmid
Journal:  Traffic       Date:  2016-08-08       Impact factor: 6.215

2.  Shape induced inhibition of phagocytosis of polymer particles.

Authors:  Julie A Champion; Samir Mitragotri
Journal:  Pharm Res       Date:  2008-06-12       Impact factor: 4.200

3.  The effects of size, shape, and surface functional group of gold nanostructures on their adsorption and internalization by cells.

Authors:  Eun Chul Cho; Leslie Au; Qiang Zhang; Younan Xia
Journal:  Small       Date:  2010-02-22       Impact factor: 13.281

4.  Altered Clathrin-Independent Endocytosis in Type A Niemann-Pick Disease Cells and Rescue by ICAM-1-Targeted Enzyme Delivery.

Authors:  Jeff Rappaport; Rachel L Manthe; Carmen Garnacho; Silvia Muro
Journal:  Mol Pharm       Date:  2015-04-23       Impact factor: 4.939

5.  A unique platform for H-Ras signaling involving clathrin-independent endocytosis.

Authors:  Natalie Porat-Shliom; Yoel Kloog; Julie G Donaldson
Journal:  Mol Biol Cell       Date:  2007-12-19       Impact factor: 4.138

6.  Visualization and in vivo tracking of the exosomes of murine melanoma B16-BL6 cells in mice after intravenous injection.

Authors:  Yuki Takahashi; Makiya Nishikawa; Haruka Shinotsuka; Yuriko Matsui; Saori Ohara; Takafumi Imai; Yoshinobu Takakura
Journal:  J Biotechnol       Date:  2013-04-02       Impact factor: 3.307

7.  Cellular Uptake and Distribution of Gemini Surfactant Nanoparticles Used as Gene Delivery Agents.

Authors:  Wei Jin; Mays Al-Dulaymi; Ildiko Badea; Scot C Leary; Jeveria Rehman; Anas El-Aneed
Journal:  AAPS J       Date:  2019-08-06       Impact factor: 4.009

Review 8.  Transferrin receptor ligand-targeted toxin conjugate (Tf-CRM107) for therapy of malignant gliomas.

Authors:  Michael Weaver; Douglas W Laske
Journal:  J Neurooncol       Date:  2003-10       Impact factor: 4.130

9.  CD47 (integrin-associated protein) engagement of dendritic cell and macrophage counterreceptors is required to prevent the clearance of donor lymphohematopoietic cells.

Authors:  B R Blazar; F P Lindberg; E Ingulli; A Panoskaltsis-Mortari; P A Oldenborg; K Iizuka; W M Yokoyama; P A Taylor
Journal:  J Exp Med       Date:  2001-08-20       Impact factor: 14.307

10.  Identification of phagocytosis regulators using magnetic genome-wide CRISPR screens.

Authors:  Michael S Haney; Christopher J Bohlen; David W Morgens; James A Ousey; Amira A Barkal; C Kimberly Tsui; Braeden K Ego; Roni Levin; Roarke A Kamber; Hannah Collins; Andrew Tucker; Amy Li; Daan Vorselen; Lorenzo Labitigan; Emily Crane; Evan Boyle; Lihua Jiang; Joanne Chan; Esther Rincón; William J Greenleaf; Billy Li; Michael P Snyder; Irving L Weissman; Julie A Theriot; Sean R Collins; Ben A Barres; Michael C Bassik
Journal:  Nat Genet       Date:  2018-11-05       Impact factor: 38.330

View more
  6 in total

1.  Nucleosomes enter cells by clathrin- and caveolin-dependent endocytosis.

Authors:  Huawei Wang; Xiajing Shan; Mengtian Ren; Mengdi Shang; Chuanzheng Zhou
Journal:  Nucleic Acids Res       Date:  2021-12-02       Impact factor: 16.971

Review 2.  Understanding the Phagocytosis of Particles: the Key for Rational Design of Vaccines and Therapeutics.

Authors:  Silvia Moreno-Mendieta; Daniel Guillén; Nathaly Vasquez-Martínez; Rogelio Hernández-Pando; Sergio Sánchez; Romina Rodríguez-Sanoja
Journal:  Pharm Res       Date:  2022-06-23       Impact factor: 4.580

Review 3.  Insight into Extracellular Vesicle-Cell Communication: From Cell Recognition to Intracellular Fate.

Authors:  Lana Ginini; Salem Billan; Eran Fridman; Ziv Gil
Journal:  Cells       Date:  2022-04-19       Impact factor: 7.666

4.  Sequentially targeting and intervening mutual Polo-like Kinase 1 on CAFs and tumor cells by dual targeting nano-platform for cholangiocarcinoma treatment.

Authors:  Yue Zhou; Lei Xu; Zhangding Wang; Hongwen Liu; Xiang Zhang; Chuanjun Shu; Meng Zhang; Ting Wang; Xinyun Xu; Xiaohong Pu; Jian He; Pin Wang; Yudong Qiu; Guifang Xu; Xiaoping Zou; Yun Zhu; Lei Wang
Journal:  Theranostics       Date:  2022-05-09       Impact factor: 11.600

5.  Surface-Fabrication of Fluorescent Hydroxyapatite for Cancer Cell Imaging and Bio-Printing Applications.

Authors:  Weimin Wan; Ziqi Li; Xi Wang; Fei Tian; Jian Yang
Journal:  Biosensors (Basel)       Date:  2022-06-15

Review 6.  Polymeric Drug Delivery System Based on Pluronics for Cancer Treatment.

Authors:  Jialin Yu; Huayu Qiu; Shouchun Yin; Hebin Wang; Yang Li
Journal:  Molecules       Date:  2021-06-12       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.